My expectation/hope for Monday:
DFA agree to waive current obligations pending ShORe result.
ShORe trial unmasked this week.
Data analysed this week.
Full announcement Monday.
need >4 letters for share price to hold. Smaller revenue opportunity but its not game over if we can get >4 letters.
Next step would then be FDA approval for approval with one phase 3 trial (can be considered based on size of phase 2 trials) and a licensing partner.
Binary outcome but above sums up what I’m reading from multiple brokers in a best case scenario.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| OPT (ASX) Chart |
Day chart unavailable